eIF3 ζ Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF3 ζ monoclonal antibodies for investigating the role of eIF3 ζ in cellular processes. eIF3 ζ Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 ζ is a critical component of the eukaryotic translation initiation factor 3 complex, playing a vital role in the regulation of protein synthesis. eIF3 ζ is involved in the recruitment of mRNA and the assembly of the ribosomal subunits, making it essential for proper cellular function and growth. Research has shown that abnormal expression of eIF3 ζ is linked to various diseases, including cancer, highlighting its significance as a target for therapeutic intervention. Understanding eIF3 ζ function and regulation can provide valuable insights into cellular mechanisms and disease pathways. Investigating eIF3 ζ may lead to breakthroughs in cancer research and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of eIF3 ζ and its impact on human health.